Cognition in the Finnish Diabetes Prevention Study

Diabetes Research and Clinical Practice

Volumn 108, Issue 3, 2015, Pages e63-e66

  Luchsinger, José A ^a   Lehtisalo, Jenni ^b   Lindström, Jaana ^b   Ngandu, Tiia ^b   Kivipelto, Miia ^c   Ahtiluoto, Satu ^b   Ilanne Parikka, Pirjo ^d   Keinänen Kiukaanniemi, Sirkka ^e   Eriksson, Johan G ^b   Uusitupa, Matti ^f   Tuomilehto, Jaakko ^b,g,h,i  

^a Department of Medicine   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Finnish Diabetes Association   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

^g DANUBE UNIVERSITY KREMS   (Austria)

^h HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

ⁱ KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Cognition; Diabetes; Impaired glucose tolerance; Lifestyle

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; COGNITION; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; FINN (CITIZEN); FOLLOW UP; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PSYCHOLOGIC ASSESSMENT; RANDOMIZATION; THERAPY EFFECT; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; FINLAND; GLUCOSE INTOLERANCE; LIFESTYLE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MULTICENTER STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION;

AGED; COGNITION; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; GLUCOSE INTOLERANCE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; RISK REDUCTION BEHAVIOR;

EID: 84930182697     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.02.023     Document Type: Article

References (19)

1. Biessels G.J., Deary I.J., Ryan C.M. Cognition and diabetes: a lifespan perspective. Lancet Neurol 2008, 7:184-190.
2. Luchsinger J.A., Tang M.X., Stern Y., Shea S., Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001, 154:635-641.
3. Luchsinger J.A., Reitz C., Patel B., Tang M.X., Manly J.J., Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007, 64:570-575.
4. Cheng D., Noble J., Tang M.X., Schupf N., Mayeux R., Luchsinger J.A. Type 2 diabetes and late-onset Alzheimer's disease. Dement Geriatr Cogn Disord 2011, 31:424-430.
5. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
6. Lindstrom J., Peltonen M., Eriksson J.G., Ilanne-Parikka P., Aunola S., Keinanen-Kiukaanniemi S., et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 2013, 56:284-293.
7. Luchsinger J.A. Type 2 diabetes, related conditions, in relation and dementia: an opportunity for prevention?. J Alzheimer's Dis: JAD 2010, 20:723-736.
8. Eriksson J., Lindstrom J., Valle T., Aunola S., Hamalainen H., Ilanne-Parikka P., et al. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the diabetes prevention study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999, 42:793-801.
9. World Health Organization Diabetes mellitus: report of a WHO study group. WHO Tech Rep Ser 1985, 727:7-113.
10. Lehtovirta M., Soininen H., Helisalmi S., Mannermaa A., Helkala E.L., Hartikainen P., et al. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996, 46:413-419.
11. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989, 39:1159-1165.
12. Reitan R.M. The relation of the trail making test to organic brain damage. J Consult Psychol 1955, 19:393-394.
13. Chandler M.J., Lacritz L.H., Hynan L.S., Barnard H.D., Allen G., Deschner M., et al. A total score for the CERAD neuropsychological battery. Neurology 2005, 65:102-106.
14. Espeland M.A., Rapp S.R., Bray G.A., Houston D.K., Johnson K.C., Kitabchi A.E., et al. Long-term impact of behavioral weight loss intervention on cognitive function. J Gerontol, A Biol Sci Med Sci 2014, 69:1101-1108.
15. Pi-Sunyer X., Blackburn G., Brancati F.L., Bray G.A., Bright R., Clark J.M., et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007, 30:1374-1383.
16. Colcombe S., Kramer A.F. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci 2003, 14:125-130.
17. Chalmers J., Cooper M.E. UKPDS and the legacy effect. N Engl J Med 2008, 359:1618-1620.
18. Paajanen T., Hanninen T., Tunnard C., Mecocci P., Sobow T., Tsolaki M., et al. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study. J Alzheimer's Dis: JAD 2010, 22:1089-1097.
19. Thal L.J., Kantarci K., Reiman E.M., Klunk W.E., Weiner M.W., Zetterberg H., et al. The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis Assoc Disord 2006, 20:6-15.